Muscle Energy Technique Versus Strain Counterstrain for Upper Trapezius Myofascial Pain Syndrome

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05925205
Collaborator
(none)
54
1
3
19.8
2.7

Study Details

Study Description

Brief Summary

This study will be conducted to examine the superiority of effectiveness between muscle energy technique combined with physical therapy, strain counterstrain combined with physical therapy, and physical therapy alone in terms of pain intensity, pain pressure threshold, cervical lateral flexion and rotation range of motion, and neck function for patients with upper trapezius myofascial trigger points.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Muscle energy technique combined with the physical therapy program.
  • Procedure: Strain counterstrain technique combined with the physical therapy program
  • Procedure: The physical therapy program
N/A

Detailed Description

Myofascial pain syndrome represents a common, overlooked, and under-diagnosed disorder that have very critical negative effects on people's lives. In addition, it overloads the societies and causes several burdens on healthcare systems. However, this disorder is usually dismissed by many clinicians keeping the patients in pain for long periods. The central feature of myofascial pain syndrome is the myofascial trigger points that when managed properly, the painful symptoms disappear. Muscle energy technique and strain counterstrain immediate effects were compared in a recent comparative study for patients with upper trapezius myofascial trigger points in terms of pain intensity, pain pressure threshold, and neck mobility. The results showed that there were improvements of both techniques with no significant differences between them. Regarding the evidence of the two techniques; muscle energy technique and strain counterstrain in the management of patients with upper trapezius myofascial trigger points, there is lack of high-quality evidence investigating the effectiveness and safety of both techniques for this population and there is a need for well-developed randomized controlled trial to take a step in the pyramid of levels of evidence for the use and applicability of them. After reviewing the available literature, it was found that there is no study directly combined both techniques with physical therapy protocol in a randomized clinical trial for patients with upper trapezius myofascial trigger points; this will enable us to compare the effects of them in a controlled design to examine and find out the differences between the three treatment protocols.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trialRandomized controlled trial
Masking:
Double (Participant, Investigator)
Masking Description:
Firstly, the research assistant, another qualified physical therapist, performing the assessment process, pre and post-treatment, will be blinded regarding the patients allocation into the three treatment groups. Secondly, the patients themselves will be blinded regarding which treatment group they will be allocated into. So the research assistant won't know the randomization results, and the main investigator won't know the assessment results which will make it a double-blinded study.
Primary Purpose:
Treatment
Official Title:
Muscle Energy Technique Versus Strain Counterstrain in Treatment of Upper Trapezius Myofascial Pain Syndrome: A Double-Blinded Randomized Controlled Trial
Actual Study Start Date :
May 7, 2023
Anticipated Primary Completion Date :
May 7, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group A

Experimental group 1.

Procedure: Muscle energy technique combined with the physical therapy program.
A manual therapy technique

Experimental: Group B

Experimental group 2.

Procedure: Strain counterstrain technique combined with the physical therapy program
A manual therapy technique

Experimental: Group C

Experimental group 3.

Procedure: The physical therapy program
Electrotherapy and exercise.

Outcome Measures

Primary Outcome Measures

  1. Change in pain intensity. [Change from Baseline pain intensity at one month.]

    Measurement of pain intensity using the visual analogue scale.

  2. Change in the right side pain pressure threshold. [Change from Baseline right side pain pressure threshold at one month.]

    Measurement of right side pain pressure threshold using the pressure algometer.

  3. Change in the left side pain pressure threshold. [Change from Baseline left side pain pressure threshold at one month.]

    Measurement of left side pain pressure threshold using the pressure algometer.

  4. Change in cervical flexion range of motion. [Change from Baseline cervical flexion range of motion at one month.]

    Measurement of cervical flexion range of motion using the cervical range of motion device.

  5. Change in cervical extension range of motion. [Change from Baseline cervical extension range of motion at one month.]

    Measurement of cervical extension range of motion using the cervical range of motion device.

  6. Change in cervical right lateral flexion range of motion. [Change from Baseline cervical right lateral flexion range of motion at one month.]

    Measurement of cervical right lateral flexion range of motion using the cervical range of motion device.

  7. Change in cervical left lateral flexion range of motion. [Change from Baseline cervical left lateral flexion range of motion at one month.]

    Measurement of cervical left lateral flexion range of motion using the cervical range of motion device.

  8. Change in cervical right rotation range of motion. [Change from Baseline cervical right rotation range of motion at one month.]

    Measurement of cervical right rotation range of motion using the cervical range of motion device.

  9. Change in cervical left rotation range of motion. [Change from Baseline cervical left rotation range of motion at one month.]

    Measurement of cervical left rotation range of motion using the cervical range of motion device.

  10. Change in neck function. [Change from Baseline neck function at one month.]

    Measurement of neck function using the neck disability index-Arabic version.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

Patients will be included in the study if they fulfil the following criteria:
  1. They have active myofascial trigger points in the upper trapezius muscle bilaterally according to the established criteria for myofascial trigger points examination.

  2. They have neck pain less than three months.

  3. Their age ranges from 18 to 40 years old. Exclusion Criteria

Patients will be excluded from the study if they fulfil the following criteria:
  1. Patients with chronic pain syndrome.

  2. Patients having myofascial trigger points in other neck muscles.

  3. Patients having a history of an injury or surgery or instability or deformity including both; cervical spine and shoulder.

  4. Patients diagnosed with a neurological disorder including altered sensation, migraine, cervical spondylosis, radiculopathy, or myelopathy, and tumour.

  5. Patients with a systemic disease including rheumatoid arthritis, Reiter's syndrome, diabetes, fibromyalgia syndrome, and severe medical or psychiatric disorders.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Outpatient Clinics, Faculty of Physical Therapy Kafrelsheikh University Kafr Ash Shaykh Egypt

Sponsors and Collaborators

  • Cairo University

Investigators

  • Study Director: Bassem El Nahass, PhD, Professor of Orthopaedic Physical Therapy, Faculty of Physical Therapy, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mona Mohamed Ibrahim, Principal Investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT05925205
Other Study ID Numbers:
  • P.T. 2023-2025
First Posted:
Jun 29, 2023
Last Update Posted:
Jun 29, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mona Mohamed Ibrahim, Principal Investigator, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 29, 2023